Whitehawk Therapeutics (WHWK) Assets Growth (5y) (2015 - 2026)
Whitehawk Therapeutics (WHWK) Assets Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.32% |
| Dec 31, 2025 | 51.62% |
| Sep 30, 2025 | 27.37% |
| Jun 30, 2025 | 31.65% |
| Mar 31, 2025 | 45.65% |
| Dec 31, 2024 | 11.98% |
| Sep 30, 2024 | 13.47% |
| Jun 30, 2024 | 15.42% |
| Mar 31, 2024 | 15.07% |
| Dec 31, 2023 | 15.61% |
| Sep 30, 2023 | 14.76% |
| Jun 30, 2023 | 16.81% |
| Mar 31, 2023 | 63.21% |
| Dec 31, 2022 | 54.35% |
| Sep 30, 2022 | 49.49% |
| Jun 30, 2022 | 33.98% |
| Mar 31, 2022 | 31.44% |
| Dec 31, 2021 | 131.07% |
| Sep 30, 2021 | 635.58% |
| Jun 30, 2021 | 350.01% |